openPR Logo
Press release

Fungal Infections Market is Projected to Boost The Market Growth at a Healthy CAGR of ~ 4.2% During The Forecast Period 2017-2023

01-24-2018 05:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Fungal Infections Market is Projected to Boost The Market Growth

Fungal endocarditis is an infection of the heart’s inner lining, known as the endocardium. The etiologic fungi more commonly observed are the Candida and Aspergillus species.

The gold standard for the diagnosis of fungal endocarditis is culture and the isolation of etiologic agents from infected valves, emboli, and other materials collected by different invasive methods such as surgery.

A number of factor such as rising incidents of fungal endocarditis, increasing awareness about fungal infections, improving regulatory framework, increasing government assistance, and rising funding and reimbursement are propelling the growth of the global fungal endocarditis market.

However, challenges in research and development, side-effects of treatment, presence of misbranded and spurious drugs and poor healthcare system in low and middle-income countries may hamper the growth of the market.

It is estimated that the fungal endocarditis market is expected to grow at a CAGR 4.2% during the forecast period of 2017-2023.

Get a sample report at https://www.marketresearchfuture.com/sample_request/5115 .

The Americas dominate the fungal endocarditis market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.

Europe holds the second position in the fungal endocarditis market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in healthcare is likely to drive the market of the Europe region.

The Asia Pacific is the fastest growing fungal endocarditis market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also increasing in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest market share due to lack of technical knowledge and poor medical facilities.

Segmentation

The global fungal endocarditis market is segmented on the basis of type of causative agent, diagnosis, treatment, and end-user.

On the basis of the type of causative agent, the market is segmented into Candida species

Aspergillus species, and Histoplasma capsulatum.

On the basis of the diagnosis, the market is classified into physical examination, blood test, X-ray, echocardiography, and electrocardiogram

On the basis of the treatment, the market is classified as antifungal medication, surgery, and combined treatment. The antifungal medication is further segmented into voriconazole, amphotericin B (AMB), itraconazole, caspofungin, echinocandins, others.

On the basis of the end-users, the market is segmented into hospital, clinics, diagnostic centers, and others.

Browse Complete Report at https://www.marketresearchfuture.com/reports/fungal-endocarditis-market-5115 .

Key Players

Some of key the players in the global fungal endocarditis market are Pfizer, Merck & Co., Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Enzon Pharmaceuticals, Inc., Bayer AG, Sigma-Aldrich, Abbott Laboratories, Eli Lily and Company, and Others.

Notably, rising awareness about fungal infections is the key factor driving the fungal endocarditis market. Nowadays, people are becoming more aware about the different types of fungal infections. Government and other different organizations have started educating people about the hygiene and infectious diseases. People are becoming more aware and conscious about the diseases. Thus, increasing awareness has provided a push to the growth of the market.

Various other push factors such as increasing incidents of fungal infections, increasing government assistance, improving regulatory framework, and rising funding and reimbursement continuously contributing to the growth of the global fungal endocarditis market.

Despite these drivers, there are some issues associated with fungal endocarditis market. Some of the challenges in research and development are side-effects of treatment, presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries, which may hinder the growth of the market to an extent. In contrast to the remedial effects, antifungal treatment can have many side effects as well. Some of them include: irritation, itching, headache, diarrhoea, and anaemia. They are also responsible for causing kidney and liver damage. Beside this, many antifungal medicines can cause allergic reactions, thus, they are not prescribed to pregnant women and children.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fungal Infections Market is Projected to Boost The Market Growth at a Healthy CAGR of ~ 4.2% During The Forecast Period 2017-2023 here

News-ID: 916082 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Fungal

Anti-Fungal Drugs Market Projected to Witness Growth Amid Rising Fungal Infectio …
Anti-Fungal Drugs Market Insights The Anti-Fungal Drugs Market has emerged as a critical segment within pharmaceutical care, offering a broad spectrum of therapeutic agents-ranging from azoles and echinocandins to polyenes-that directly address fungal infections in immunocompromised patients, dermatological cases, and systemic mycoses. These products deliver advantages such as improved bioavailability, targeted delivery, and reduced side effects compared to earlier treatments. Growing incidences of hospital-acquired Candida and Aspergillus infections, coupled with an
Fungal Testing Kits Market - Defend Against Fungal Intruders: Fungal Testing Kit …
Newark, New Castle, USA: The "Fungal Testing Kits Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Fungal Testing Kits Market: https://www.growthplusreports.com/report/fungal-testing-kits-market/8888 This latest report researches the industry structure,
Fungal Testing Kits Market - Fungal Testing Made Easy: Unleashing Confidence wit …
Newark, New Castle, USA - new report, titled Fungal Testing Kits Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fungal Testing Kits market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fungal Testing Kits market. The report offers an overview of
Global Fungal Protein Industry Analysis By Geography
Stratistics MRC's Fungal Protein Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Fungal protein, which is also known as mycoprotein, is low in caloric content and rich in protein. Its richness in fiber content has made the protein sought-after for limiting the fat intake. These are single-cell proteins used in pharmaceuticals, food and beverage and animal feed industries. Products including fusarium venenatum and yeast
2028 Fungal Protein Industry Report Growth Forecasts
Stratistics MRC's Global Fungal Protein Market value expected to reach $8.25 billion growing at a CAGR of 10% during 2020-2028. Fungal protein, which is also known as mycoprotein, is low in caloric content and rich in protein. Its richness in fiber content has made the protein sought-after for limiting the fat intake. These are single-cell proteins used in pharmaceuticals, food and beverage and animal feed industries. Products including fusarium venenatum and
Anti-fungal Drugs Market - Increasing Accessibility To Low-Cost OTC Anti-Fungal …
As the name suggests, anti-fungal drugs are used to treat fungal infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Fungal infection is usually associated with a weak immune system, with people suffering from HIV and